Literature DB >> 4370358

Selective thymic localization of murine leukemia virus-related antigens in C57BL-Ka mice after inoculation with radiation virus.

A Declève, C Sato, M Lieberman, H S Kaplan.   

Abstract

The tissue distribution and extent of virus-specific antigen expression were studied by immunofluorescence as a function of time and of lymphoma development in adult C57BL/Ka (Fv-1(b)) mice after intravenous injection of radiation leukemia virus, a B-tropic murine leukemia virus. Viral antigens were detected earlier in the thymus (1 week) than in the bone marrow, spleen, or lymph nodes (2-3 weeks). Despite an initial virus-induced thymic involution, the percentage of immunofluorescence-positive cells in the thymus rapidly increased thereafter to 65-80%, at which level it remained until 9 weeks, at which time increases in size and weight, histological changes, and an increased number of blastoid cells indicated the onset of lymphoma development in the thymus. In contrast, the percentage of immunofluorescence-positive cells in the bone marrow, spleen, and nodes remained low, and gradually decreased to zero within 8 weeks after thymectomy. The selective thymic localization of antigens induced by radiation leukemia virus in C57BL/Ka mice is in striking contrast to the previously reported ubiquitous tissue distribution of the Gross-AKR virus, an N-tropic virus, in its natural host, the Fv-1(n), AKR strain with a high incidence of leukemia.

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4370358      PMCID: PMC388634          DOI: 10.1073/pnas.71.8.3124

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  UNILATERAL HISTOGENESIS OF AKR THYMIC LYMPHOMA.

Authors:  R SIEGLER; M A RICH
Journal:  Cancer Res       Date:  1963-11       Impact factor: 12.701

2.  Urethan induction of thymic lymphoma in C57bl mice.

Authors:  R G DOELL; W H CARNES
Journal:  Nature       Date:  1962-05-12       Impact factor: 49.962

3.  Analysis of the thymus influence in leukaemogenesis.

Authors:  J F MILLER
Journal:  Nature       Date:  1961-07-15       Impact factor: 49.962

4.  Influence of thymectomy, splenectomy, and gonadectomy on incidence of radiation-induced lymphoid tumors in strain C57 black mice.

Authors:  H S KAPLAN
Journal:  J Natl Cancer Inst       Date:  1950-08       Impact factor: 13.506

5.  Adaptation of plaque assay methods to the in vitro quantitation of the radiation leukemia virus.

Authors:  O Niwa; A Decléve; M Liberman; H S Kaplan
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

6.  Interrelationships of myeloid and lymphoid cells: studies with chromosome-marked cells transfused into lethally irradiated mice.

Authors:  H S Micklem; C E Ford; E P Evans; J Gray
Journal:  Proc R Soc Lond B Biol Sci       Date:  1966-07-19

7.  Lymphoid tumor induction by mouse thymocytes infected in vitro with radiation leukemia virus.

Authors:  M Lieberman; H S Kaplan
Journal:  Natl Cancer Inst Monogr       Date:  1966-09

8.  Regneration of thymus, spleen and bone marrow in x-irradiated AKR mice.

Authors:  A Decleve; G B Gerber; A Leonard; M Lambiet-Collier; A Sassen; J R Maisin
Journal:  Radiat Res       Date:  1972-08       Impact factor: 2.841

9.  A leukemogenic filtrable agent from chemically-induced lymphoid leukemia in C57BL mice.

Authors:  N Haran-Ghera
Journal:  Proc Soc Exp Biol Med       Date:  1967-03

10.  Mouse leukemia virus activation by chemical carcinogens.

Authors:  H J Igel; R J Huebner; H C Turner; P Kotin; H L Falk
Journal:  Science       Date:  1969-12-26       Impact factor: 47.728

View more
  19 in total

1.  DNA-binding proteins that interact with the long terminal repeat of radiation leukemia virus.

Authors:  I Gorska-Flipot; P Jolicoeur
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

2.  In vitro infection of lymphoid cells by thymotropic radiation leukemia virus grown in vitro.

Authors:  M Haas; J Hilgers
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

3.  Proviral genome of radiation leukemia virus: molecular cloning of biologically active proviral DNA and nucleotide sequence of its long terminal repeat.

Authors:  M Janowski; J Merregaert; J Boniver; J R Maisin
Journal:  J Virol       Date:  1985-07       Impact factor: 5.103

4.  Studies on emerging radiation leukemia virus variants in C57BL/Ka mice.

Authors:  E Rassart; M Shang; Y Boie; P Jolicoeur
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

5.  Control of RFM strain endogenous retrovirus in RFM mouse cells.

Authors:  R W Tennant; J A Otten; T W Wang; R S Liou; A Brown; W K Yang
Journal:  J Virol       Date:  1983-01       Impact factor: 5.103

6.  Frequent isolation of ecotropic murine leukemia virus after x-ray irradiation of C57BL/6 mice and establishment of producer lymphoid cell lines from radiation-induced lymphomas.

Authors:  P Sankar-Mistry; P Jolicoeur
Journal:  J Virol       Date:  1980-07       Impact factor: 5.103

7.  In vitro generation of cytotoxic lymphocytes against radiation- and radiation leukemia virus-induced tumors. III. Suppression of anti-tumor immunity in vitro by lymphocytes of mice undergoing radiation leukemia virus-induced leukemogenesis.

Authors:  E Yefenof; A Meidav; E Kedar
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

8.  Identification of a novel gene, Vin-1, in murine leukemia virus-induced T-cell leukemias by provirus insertional mutagenesis.

Authors:  P J Tremblay; C A Kozak; P Jolicoeur
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

9.  Association of endogenous retroviruses with radiation-induced leukemias of BALB/c mice.

Authors:  R W Ellis; E Stockert; E Fleissner
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

10.  U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.

Authors:  I Gorska-Flipot; M Huang; M Cantin; E Rassart; G Massé; P Jolicoeur
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.